Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes
מצבים רפואיים
Chronic Obstructive Pulmonary Disease COPD
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Investigational Site Number : 2500021, Aix-en-Provence, France
Investigational Site Number : 2500043, Blois, France
Investigational Site Number : 2500044, Brest, France
Investigational Site Number : 2500009, Colmar, France
Investigational Site Number : 2500031, Contamine-sur-Arve, France
Investigational Site Number : 2500022, Juan-les-Pins, France
Investigational Site Number : 2500020, Le Chesnay, France
Investigational Site Number : 2500038, Libourne, France
Investigational Site Number : 2500033, Lyon, France
Investigational Site Number : 2500024, Marseille, France
Investigational Site Number : 2500002, Montpellier, France
Investigational Site Number : 2500047, Morlaix, France
Investigational Site Number : 2500040, Niort, France
Investigational Site Number : 2500026, Nîmes, France
Investigational Site Number : 2500017, Paris, France
Investigational Site Number : 2500001, Pessac, France
Investigational Site Number : 2500034, Pierre-Bénite, France
Investigational Site Number : 2500048, Saint-Pierre, France
Investigational Site Number : 2500028, Toulouse, France
Investigational Site Number : 2500029, Toulouse, France
Investigational Site Number : 2500010, Vantoux, France
Investigational Site Number : 2500035, Villeurbanne, France